21 – 40 of 41
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming
(
- Contribution to journal › Article
-
Mark
Direct Reprogramming of Resident NG2 Glia into Neurons with Properties of Fast-Spiking Parvalbumin-Containing Interneurons
(
- Contribution to journal › Article
-
Mark
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways
(
- Contribution to journal › Article
- 2016
-
Mark
Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?
(
- Contribution to journal › Scientific review
- 2015
-
Mark
In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry.
(
- Contribution to journal › Article
- 2014
-
Mark
Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors.
(
- Contribution to journal › Article
-
Mark
Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain.
(
- Contribution to journal › Article
- 2013
-
Mark
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.
(
- Contribution to journal › Article
-
Mark
Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action.
(
- Contribution to journal › Article
-
Mark
Restoration of synaptic plasticity in the host striatum: can transplants make it?
2013) In NeuroReport(
- Contribution to journal › Article
- 2012
-
Mark
The serotonin system: a potential target for anti-dyskinetic treatments and biomarker discovery.
(
- Contribution to journal › Article
- 2011
-
Mark
Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
(
- Contribution to journal › Article
- 2010
-
Mark
Involvement of non-dopaminergic systems in L-DOPA-induced dyskinsia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias
(
- Contribution to journal › Article
-
Mark
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
(
- Contribution to journal › Article
-
Mark
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.
(
- Contribution to journal › Article
- 2009
-
Mark
Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalling.
(
- Contribution to journal › Article
-
Mark
Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia.
(
- Contribution to journal › Article